Complete financial analysis of Aarti Industries Limited (AARTIIND.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aarti Industries Limited, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- STS Group AG (SF3.DE) Income Statement Analysis – Financial Results
- Candel Therapeutics, Inc. (CADL) Income Statement Analysis – Financial Results
- BridgeBio Pharma, Inc. (BBIO) Income Statement Analysis – Financial Results
- Beijing Gas Blue Sky Holdings Limited (6828.HK) Income Statement Analysis – Financial Results
- Weikeng Industrial Co., Ltd. (3033.TW) Income Statement Analysis – Financial Results
Aarti Industries Limited (AARTIIND.BO)
About Aarti Industries Limited
Aarti Industries Limited manufactures and sells specialty chemicals and pharmaceuticals in India. The company offers di chloro benzene, nitro chloro and nitro benzene, nitro toluenes, sulphur, and other organic and inorganic products that are used in various processes, such as chlorination, nitration, hydrogenation, ammonolysis, halex, dinitro chlorination, alkylation, hydrolysis, methoxylation, esterification, diazotization, sulphonation, condensation, n-alkylation, and oxidation. It also provides end use products comprising dyes, basic pharma, pigments, agro chemicals, polymers, fertilizers, UV absorbers, plasticizers, specialty chemicals, flavour fragrance and food beverage products, and refinery and oil field chemicals, as well as intermediates for the manufacture of pharmaceuticals, agri-products, polymers, additives, pigments, and dyes. In addition, the company offers other specialty chemical products, such as single super phosphate, export grade calcium chloride granules, fuel additives, and phthalates; and sulphuric acid products. It also exports its products to approximately 60 countries in the United States, Europe, China, Japan, and internationally. The company was incorporated in 1984 and is headquartered in Mumbai, India.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 63.23B | 72.83B | 60.98B | 43.05B | 41.05B | 46.59B | 37.59B | 31.15B | 27.29B | 28.61B | 25.98B | 20.58B | 16.73B | 14.84B | 13.01B | 14.61B | 8.99B | 7.64B | 8.02B | 7.07B |
Cost of Revenue | 39.93B | 38.42B | 41.94B | 28.63B | 26.69B | 32.39B | 26.81B | 21.70B | 18.88B | 21.59B | 19.67B | 15.21B | 12.74B | 11.91B | 10.33B | 11.04B | 7.41B | 6.23B | 6.19B | 5.57B |
Gross Profit | 23.30B | 34.41B | 19.04B | 14.42B | 14.36B | 14.20B | 10.78B | 9.44B | 8.41B | 7.02B | 6.32B | 5.37B | 4.00B | 2.93B | 2.69B | 3.57B | 1.58B | 1.41B | 1.83B | 1.50B |
Gross Profit Ratio | 36.85% | 47.25% | 31.22% | 33.50% | 34.98% | 30.48% | 28.68% | 30.32% | 30.83% | 24.54% | 24.31% | 26.10% | 23.88% | 19.76% | 20.65% | 24.43% | 17.56% | 18.49% | 22.80% | 21.22% |
Research & Development | 33.60M | 23.70M | 67.70M | 551.00M | 270.10M | 218.70M | 150.70M | 113.80M | 103.60M | 93.90M | 92.68M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 383.50M | 292.90M | 437.20M | 398.00M | 363.40M | 360.50M | 346.10M | 225.50M | 202.00M | 148.60M | 192.24M | 139.46M | 97.78M | 201.82M | 143.57M | 160.94M | 91.93M | 97.91M | 94.85M | 86.20M |
Selling & Marketing | 2.71B | 4.02B | 3.70B | 2.23B | 1.71B | 1.93B | 1.77B | 1.41B | 1.53B | 1.68B | 1.58B | 1.28B | 918.80M | 896.05M | 776.12M | 902.36M | 572.90M | 529.21M | 606.59M | 457.85M |
SG&A | 3.09B | 4.31B | 4.14B | 2.62B | 2.08B | 2.29B | 2.11B | 1.64B | 1.73B | 1.83B | 1.78B | 1.42B | 1.02B | 1.10B | 919.69M | 1.06B | 664.82M | 627.12M | 701.44M | 544.06M |
Other Expenses | -17.20M | 10.00M | -127.70M | -141.60M | -108.70M | -102.20M | -69.80M | -86.70M | -50.80M | -34.47M | -38.65M | -34.09M | 702.77M | 553.98M | 502.20M | 870.41M | 383.27M | 285.98M | -13.03M | -6.13M |
Operating Expenses | 15.38B | 26.62B | 2.50B | 6.77B | 6.31B | 6.04B | 5.16B | 4.03B | 3.60B | 3.14B | 3.13B | 2.53B | 2.00B | 1.40B | 1.08B | 1.47B | 606.89M | 780.08M | 926.26M | 741.10M |
Cost & Expenses | 44.07B | 65.04B | 44.44B | 35.40B | 33.00B | 38.43B | 31.97B | 25.73B | 22.47B | 24.73B | 22.79B | 17.74B | 14.74B | 13.31B | 11.41B | 12.51B | 8.02B | 7.01B | 7.11B | 6.31B |
Interest Income | 70.90M | 1.06B | 686.30M | 766.90M | 1.15B | 1.75B | 0.00 | 0.00 | 31.00M | 4.21M | 3.14M | 184.00K | 1.40M | 1.10M | 853.00K | 2.50M | 2.73M | 1.94M | 1.89M | 287.90K |
Interest Expense | 1.95B | 1.68B | 1.06B | 767.10M | 1.15B | 1.75B | 1.25B | 1.11B | 1.08B | 1.25B | 1.06B | 875.25M | 718.40M | 562.13M | 519.92M | 894.87M | 389.05M | 290.58M | 188.58M | 117.14M |
Depreciation & Amortization | 3.78B | 3.10B | 2.46B | 2.31B | 1.85B | 1.63B | 1.46B | 1.23B | 985.00M | 819.75M | 885.18M | 828.43M | 548.52M | 500.24M | 473.30M | 406.35M | 288.90M | 306.60M | 252.70M | 206.40M |
EBITDA | 9.57B | 10.35B | 16.95B | 9.82B | 9.86B | 9.67B | 7.07B | 6.54B | 5.76B | 4.75B | 4.12B | 3.57B | 2.49B | -7.62B | 2.06B | 2.49B | 1.26B | 936.56M | 1.13B | 958.02M |
EBITDA Ratio | 15.13% | 14.95% | 31.50% | 22.60% | 23.63% | 20.63% | 18.47% | 20.83% | 20.94% | 15.91% | 15.11% | 17.30% | 15.11% | 13.63% | 15.84% | 17.03% | 13.99% | 12.26% | 14.05% | 13.42% |
Operating Income | 19.66B | 7.79B | 14.74B | 7.51B | 7.92B | 8.02B | 5.62B | 5.41B | 4.82B | 3.88B | 3.19B | 2.86B | 2.00B | 1.53B | 1.60B | 2.10B | 971.70M | 632.62M | 900.95M | 759.15M |
Operating Income Ratio | 31.09% | 10.70% | 24.17% | 17.44% | 19.30% | 17.22% | 14.95% | 17.38% | 17.66% | 13.57% | 12.28% | 13.91% | 11.93% | 10.31% | 12.33% | 14.40% | 10.81% | 8.28% | 11.24% | 10.74% |
Total Other Income/Expenses | -15.70B | -16.23B | -13.40B | -11.57B | -560.70M | -1.57B | -968.70M | -822.00M | -708.60M | -1.23B | -1.13B | -968.88M | -725.77M | -569.19M | -536.78M | -916.83M | -392.10M | -293.24M | -179.43M | -126.35M |
Income Before Tax | 3.95B | 6.11B | 15.27B | 6.65B | 6.76B | 6.22B | 4.29B | 4.16B | 3.63B | 2.55B | 2.06B | 1.87B | 1.26B | 960.37M | 1.07B | 1.19B | 579.59M | 339.38M | 721.52M | 632.79M |
Income Before Tax Ratio | 6.25% | 8.39% | 25.04% | 15.44% | 16.47% | 13.35% | 11.41% | 13.34% | 13.29% | 8.90% | 7.93% | 9.08% | 7.54% | 6.47% | 8.20% | 8.12% | 6.45% | 4.44% | 9.00% | 8.95% |
Income Tax Expense | -210.50M | 650.00M | 2.19B | 1.29B | 1.29B | 1.18B | 828.60M | 880.60M | 946.30M | 610.33M | 540.26M | 537.58M | 361.60M | 291.32M | 382.74M | 316.05M | 170.90M | 86.41M | 168.31M | 153.52M |
Net Income | 4.16B | 5.45B | 11.86B | 5.23B | 5.36B | 4.92B | 3.33B | 3.16B | 2.57B | 2.06B | 1.62B | 1.34B | 1.03B | 814.81M | 823.48M | 946.12M | 465.35M | 299.74M | 553.21M | 479.28M |
Net Income Ratio | 6.59% | 7.49% | 19.44% | 12.16% | 13.06% | 10.55% | 8.86% | 10.14% | 9.41% | 7.19% | 6.25% | 6.53% | 6.17% | 5.49% | 6.33% | 6.47% | 5.18% | 3.92% | 6.90% | 6.78% |
EPS | 11.49 | 15.04 | 32.71 | 15.02 | 15.38 | 13.56 | 10.24 | 9.61 | 7.71 | 5.81 | 4.59 | 3.79 | 3.36 | 2.66 | 2.68 | 2.95 | 1.40 | 0.87 | 1.90 | 1.65 |
EPS Diluted | 11.49 | 15.04 | 32.71 | 15.02 | 15.38 | 13.56 | 10.24 | 9.61 | 7.71 | 5.81 | 4.59 | 3.79 | 3.36 | 2.66 | 2.68 | 2.95 | 1.40 | 0.87 | 1.90 | 1.65 |
Weighted Avg Shares Out | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M |
Weighted Avg Shares Out (Dil) | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M | 362.50M |
Source: https://incomestatements.info
Category: Stock Reports